Literature DB >> 2250245

Purines inhibit the development of mouse embryos in vitro.

A Nureddin1, E Epsaro, A A Kiessling.   

Abstract

The first cleavage of embryos derived from random-bred, inbred, and hybrid-inbred female mice was not arrested by purines at concentrations as high as 30 microM. Development after the first or second cleavage was arrested by hypoxanthine, adenosine or inosine, but not guanosine. In agreement with previous results, the purine-induced block was reversed when arrested embryos were transferred to purine-free media after 24 h in culture. The cleavage arrest was not due to elevations of cAMP as a result of inhibition of phosphodiesterase activity since similar concentrations of phosphodiesterase inhibitors or dibutyryl cAMP did not block development. Treatment with inhibitors of enzymes that convert IMP to AMP or to GMP did not reverse the hypoxanthine-induced block, thus demonstrating that mitotic arrest is mediated by a mechanism different from the hypoxanthine arrest of meiosis. Thymidine incorporation studies showed that the block did not prevent the onset of DNA synthesis. The results reveal a profound sensitivity to purine inhibition of a cell process that occurs during the first 30 h of mouse embryo development and is necessary for progession through the G2 or M phases of the second or third cleavage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2250245     DOI: 10.1530/jrf.0.0900455

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  10 in total

Review 1.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

2.  Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice.

Authors:  Anna E Beaudin; Cheryll A Perry; Sally P Stabler; Robert H Allen; Patrick J Stover
Journal:  Am J Clin Nutr       Date:  2012-02-29       Impact factor: 7.045

3.  Comparative genomic and expression analysis of the adenosine signaling pathway members in Xenopus.

Authors:  Alice Tocco; Benoît Pinson; Pierre Thiébaud; Nadine Thézé; Karine Massé
Journal:  Purinergic Signal       Date:  2014-10-16       Impact factor: 3.765

4.  A preliminary trial of human zygote culture in Ham's F-10 without hypoxanthine.

Authors:  D C Loutradis; A A Kiessling; K Kallianidis; K Siskos; G Creatsas; S Michalas; D Aravantinos
Journal:  J Assist Reprod Genet       Date:  1993-05       Impact factor: 3.412

5.  The in vitro development of mouse embryos beyond the blastocyst stage into the hatching and outgrowth stage using different energy sources.

Authors:  P Drakakis; D Loutradis; S Milingos; R Bletsa; K Kallianidis; S Michalas; D Aravantinos
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

6.  Minimum essential medium alpha (MEM) enhances assisted reproductive technology results. I. Mouse embryo study.

Authors:  W S Wun; C C Wun; G M Grunert
Journal:  J Assist Reprod Genet       Date:  1994-07       Impact factor: 3.412

Review 7.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

Review 8.  Purines as potential morphogens during embryonic development.

Authors:  Karine Massé; Nicholas Dale
Journal:  Purinergic Signal       Date:  2012-01-25       Impact factor: 3.765

9.  Metabolomic Analysis Evidences That Uterine Epithelial Cells Enhance Blastocyst Development in a Microfluidic Device.

Authors:  Vanessa Mancini; Alexandra C Schrimpe-Rutledge; Simona G Codreanu; Stacy D Sherrod; John A McLean; Helen M Picton; Virginia Pensabene
Journal:  Cells       Date:  2021-05-13       Impact factor: 6.600

10.  Microarray Analyses Reveal Marked Differences in Growth Factor and Receptor Expression Between 8-Cell Human Embryos and Pluripotent Stem Cells.

Authors:  Antonis Vlismas; Ritsa Bletsa; Despina Mavrogianni; Georgina Mamali; Maria Pergamali; Vasiliki Dinopoulou; George Partsinevelos; Peter Drakakis; Dimitris Loutradis; Ann A Kiessling
Journal:  Stem Cells Dev       Date:  2015-12-01       Impact factor: 3.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.